Schizophrenia - Articles - Page 3

Research Update

Does Menopause Increase Risk of Psychosis?

July 1, 2024

Briana Tillman, MD. Dr. Tillman has no financial relationships with companies related to this material.

This comprehensive study highlights the need for gender-specific treatment in schizophrenia spectrum disorders, revealing that hormonal changes call for lower antipsychotic doses for female patients under 45 and higher doses for those who are post-menopausal.

Expert Q&A

The Emerging Field of Lifestyle Psychiatry

July 1, 2024

Douglas Noordsy, MD

Douglas Noordsy, MD.

Clinical Professor and Director of Lifestyle Psychiatry; Psychiatrist, INSPIRE Early Psychosis Clinic, Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Stanford, CA.

Dr. Noordsy has no financial relationships with companies related to this material.

Dr. Noordsy highlights compelling evidence suggesting that lifestyle changes, like regular exercise and nutritious diets, can significantly improve psychiatric treatment outcomes.

Expert Q&A

Street Psychiatry: Providing Outreach and Care to the Unhoused Mentally Ill

July 1, 2024

Shayan Rab, MD

Shayan Rab, MD

Associate Medical Director, Field-Based Services, Los Angeles County Department of Mental Health, Los Angeles, CA.

Dr. Rab has no financial relationships with companies related to this material.

Dr. Rab, pioneering street psychiatrist, shares the innovative methods he uses for effective outreach to unhoused mentally ill individuals, like mobile medication delivery and personalized housing strategies.

Clinical Update

Don’t Delay: Interventions in Early Psychosis

July 1, 2024

Brian Holoyda, MD, MPH, MBA

Brian Holoyda, MD. Chief Psychiatrist, Contra Costa County Detention Health Services, Martinez, CA. Dr. Holoyda has no financial relationships with companies related to this material.

We highlight the profound difference early intervention makes in the trajectory of psychotic disorders, reducing symptom severity, suicide risk, and functional impairment.

Research Update

Sertraline in Schizophrenia

May 1, 2024

Richard Moldawsky, MD

Richard Moldawsky, MD. Dr. Moldawsky has no financial relationships with companies related to this material.

This study investigates whether augmenting risperidone with sertraline can improve negative symptoms.

Expert Q&A

A Therapeutic Approach to Schizophrenia

May 1, 2024

Mark L. Ruffalo, MSW, DPsa

Mark L. Ruffalo, MSW, DPsa.

Editor-in-Chief, The Carlat Psychotherapy Report. Psychotherapist in private practice in Tampa, Florida. Assistant Professor of Psychiatry at the University of Central Florida College of Medicine and Adjunct Instructor of Psychiatry at Tufts University School of Medicine.

Dr. Ruffalo has no financial relationships with companies related to this material.

Dr. Ruffalo discusses ways to build trust and address patients' goals in managing schizophrenia symptoms.

Expert Q&A

A Therapeutic Approach to Schizophrenia

April 1, 2024

Mark L. Ruffalo, MSW, DPsa

Mark L. Ruffalo, MSW, DPsa

Editor-in-Chief, The Carlat Psychotherapy Report. Psychotherapist in private practice in Tampa, Florida. Assistant Professor of Psychiatry at the University of Central Florida College of Medicine and Adjunct Instructor of Psychiatry at Tufts University School of Medicine.

Dr. Ruffalo has no financial relationships with companies related to this material.

How do you establish trust with patients who have psychosis? Dr. Ruffalo: Shorter sessions are more appropriate for psychotherapy with schizophrenia, like 30 minutes instead of the usual 45–50 minutes. Longer sessions tend to increase the patient’s interpersonal anxiety.

RESEARCH UPDATE

Metacognitive Therapy Shows Potential in Treating Schizophrenia

February 2, 2024

Batya Swift Yasgur, MA, LSW

Batya Swift, MA, LSW. Ms Swift has no financial relationships with companies related to this material.

A recent study explores a patient-centric approach designed to enhance understanding of self and others, potentially transforming the landscape of schizophrenia treatment.

Research Update

Immediate vs Extended-Release Quetiapine for Schizophrenia

January 1, 2024

Richard Moldawsky, MD

Richard Moldawsky, MD. Dr. Moldawsky has no financial relationships with companies related to this material.

A new analysis looks at the optimal dosing for quetiapine in schizophrenia, and when to use instant vs extended release.

Clinical Update

Negative Symptoms of Schizophrenia

January 1, 2024

Chris Aiken, MD and Paul Riordan, MD.

Chris Aiken, MD. Editor-in-Chief, The Carlat Psychiatry Report. Assistant Professor, NYU Langone Department of Psychiatry. Practicing psychiatrist, Winston-Salem, NC.

Paul Riordan, MD. Assistant Consulting Professor of Psychiatry, Duke University, Durham, NC.

The authors have no financial relationships with companies related to this material.

Negative symptoms are the primary cause of disability in schizophrenia, and we identify a few antipsychotics and a few add-on therapies that can help.